← Evidence map

ReviewAllergologie select2019

Allergen immunotherapy phase II trials: Challenges in dose finding.

J Kleine-Tebbe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32176223